Neodipar tablet 850 mg 3_10?s decreases absorption of glucose from the intestines and increases the action of insulin in the body. This helps in reducing the blood glucose levels.
Side effects
Major & minor side effects for Neodipar tablet 850 mg 3_10?s
Nausea and vomiting
Abdominal pain
Hypoglycemia severe
Lactic Acidosis severe
Weakness
Chest discomfort
Headache
Runny Nose
Belching and Heartburn
Swollen joints
Uses of Neodipar tablet 850 mg 3_10?s
What is it prescribed for?
Type II Diabetes Mellitus
This medicine is used along with an appropriate diet and exercise regimen to reduce blood glucose levels in patients with type 2 diabetes.
Concerns
Frequently asked questions
Onset of action
The peak effect of this medicine can be observed within 1-3 hours of administration.
Duration of Effect
The effect of this medicine lasts for an average duration of 4 to 8 hours.
Safe with Alchohol?
Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Is it habit forming?
No habit-forming tendencies were reported.
Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
When not to use?
Severe kidney impairment
This medicine is not recommended for use in patients with a severe impairment of kidney function due to the increased risk of serious adverse effects.
Allergy
This medicine is not recommended for use in patients with a known allergy to Neodipar tablet 850 mg 3_10?s or any other biguanides.
Metabolic Acidosis
This medicine is not recommended for use in patients with metabolic acidosis since it may worsen the patient’s condition.
Warnings
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General Warnings
Lactic Acidosis
This medicine may cause lactic acidosis, which may be fatal, in some patients. This risk is especially higher in patients suffering from heart diseases, kidney diseases, etc. Report any unusual symptoms to the doctor immediately. Replacement with a suitable alternative may be required based on the clinical condition.
Kidney disease
This medicine should be used with caution in patients with a known history of kidney disease due to the increased risk of worsening of the patient’s condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Alcohol use
Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of serious adverse effects.
Stress
Use of this medicine should be discontinued in patients exposed to stressful conditions such as a fever, trauma, surgeries, or accidents since it may not be effective in controlling blood sugar levels in these conditions. Replacement with a suitable alternative should be considered under your doctor’s supervision.
Type I diabetes
This medicine is not recommended for use in patients suffering from Type I diabetes since it is not effective in treating such patients.
Diarrhea
This medicine may cause diarrhea when therapy is initiated. In most cases, diarrhea subsides by itself. Contact your doctor if the problem persists for longer durations. Therapy may need to be discontinued in some cases based on the clinical condition.
Vitamin B12 deficiency
This medicine should be used with extreme caution in patients with vitamin B12 deficiency since it may worsen the patient’s condition. Appropriate vitamin B12 supplementation and dose adjustments may be required in some cases.
Dosage
Missed Dose
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up for the missed dose.
Overdose
Contact a doctor immediately if an overdose is suspected. Some overdosages could lead to Lactic Acidosis which requires immediate medical intervention.
Interactions
Interaction with Medicines
Amlodipine moderate
Estradiol moderate
Gatifloxacin severe
Iodinated Contrast Media severe
Aloe Vera moderate
Disease interactions
moderate
This medicine should be used with extreme caution in patients with vitamin B12 deficiency since it may worsen the patient’s condition. Appropriate vitamin B12 supplementation and dose adjustments may be required based on the clinical condition.
General Instructions
Take Neodipar tablet 850 mg 3_10?s exactly as prescribed by the doctor. Your dose is likely to change over time based on therapeutic response and clinical condition. Regular monitoring of blood sugar levels is recommended during treatment with this medicine. You should always carry a sugar candy with you to counteract unexpected lowering of blood sugar levels. Do not change the dose or duration of use without consulting your doctor.
Other details
To be taken with food
To be taken as instructed by doctor
May cause sleepiness
References
practo.com –
Metformin [Internet].
Available from: https://www.practo.com/medicine-info/metformin-176-api
[cited 18 september 2019].
14 May 2018
dailymed.nlm.nih.gov –
Metformin [Internet].
Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d98aea3-35ba-447a-b88f-a5a20b612b2f
[cited 18 september 2019].
February 7, 2017
Reviews
There are no reviews yet.